|
|
|
Welcome to the Quality Counts. For those health conscious consumers and medical professionals that are looking to purchase nutritional supplements, vitamins, herbs, learning about medications, losing weight, health food, low carbs, high protein nutrition, and exercise, you have come to the right place. Quality Counts serves both the medical practitioner and consumer interested in nutritional therapy and alternative medicine.
Home > Health Condition > Alzheimer's Disease > Exelon
Exelon (rivastigmine tartrate)
Related Topics:
News & Research:
-
First Alzheimer's patch gets approval - USA Today, 7/9/07
-
Drug
Improves Memory Loss For Traumatic Brain Injury Patients - Science
Daily, 9/18/06
-
Rivastigmine Good Choice For Parkinson's Dementia - Clinical Psychiatry
News, 9/06
-
FDA OKs Drug for Parkinson's Dementia - WebMD, 6/28/06
-
The U.S. Food and Drug Administration Approves Exelon(R) (rivastigmine
tartrate) as the First Medication Indicated to Treat Parkinson's Disease
Dementia - Doctor's Guide, 6/28/06
-
Treatment of MCI With Rivastigmine: Results From the InDDEx Study -
Doctor's Guide, 4/24/06
-
Trio of Drugs May Improve Alzheimer's - WebMD, 1/25/06
-
Rivastigmine (Exelon) Safe and Effective Alternative for Alzheimer's
Patients Not Responding Adequately to Donepezil (Aricept) - Doctor's
Guide, 5/31/05
-
Rivastigmine Treatment for Alzheimer's Disease Cuts Need for Antipsychotics
- Doctor's Guide, 4/12/05
-
Rivastigmine May Delay Dementia in Parkinson's - Clinical Psychiatry
News, 4/05
- Quetiapine and Rivastigmine Not Often Helpful for Agitation in Alzheimer's Disease - Medscape, 2/22/05
- Exelon (Rivastigmine Tartrate) May Help People With Dementia Associated With Parkinson's Disease - Doctor's Guide, 12/9/04
- Rivastigmine May Be Helpful for the Dementia of PD - Medscape, 12/8/04
-
Rivastigmine Benefits Dementia in Parkinson's - Clinical Psychiatry News, 11/04
- Rivastigmine May Be More Effective in Patients with More Rapid Alzheimer's Progression - Doctor's Guide, 10/12/04
-
Rivastigmine May Slow Alzheimer's Progression - Clinical Psychiatry News, 7/04
- Rivastigmine Shows Sustained Efficacy in Alzheimer's Patients - Doctor's Guide, 6/21/04
- Rivastigmine May Slow Progression of Moderately Severe Alzheimer's Disease - Doctor's Guide, 4/15/04
- Alzheimer's Drug [Exelon] May Slow Down Disease - WebMD, 2/25/04
- Drug Interactions with Cholinesterase Inhibitors: a Review - Doctor's Guide, 10/23/03
-
Rivastigmine Switch Well Tolerated - Clinical Psychiatry News, 10/03
- Exelon (Rivastigmine Tartrate) Reduces Behavioral Disturbances Associated With Alzheimer's Disease - Doctor's Guide, 8/22/03
- Drug May Slow Alzheimer's Progression - WebMD, 6/18/03
- Exelon (Rivastigmine) May Slow Progression Of Alzheimer Disease - Doctor's Guide, 6/18/03
-
Start Cholinesterase Inhibitor Immediately After Alzheimer's Dx - Clinical Psychiatry News, 6/03
- Antipsychotics Effective for Elderly Patients With Dementia - Psychiatric News, 4/18/03 -
"atypical antipsychotics have
been used to alleviate deteriorating behavioral symptoms in dementia patients, such as agitation and aggression. New research that she cited shows some atypical antipsychotics can actually improve cognition through
activating the release of acetylcholine in the cortex. Clozapine, olanzapine, and risperidone, she reported, robustly increased acetylcholine release in the cortex, while
ziprasidone only moderately increased levels, compared with haloperidol and thioridazine, which did not elevate acetylcholine levels at all
... atypical antipsychotics increase cortical dopamine and cholinesterase inhibitors at the very least increase cortical acetylcholine action, leading to an
improvement in memory and thinking, as well as improvement in psychosis and behavior"
- Alzheimer’s Drugs May Offer Psychiatric Benefits - psychiatryonline.org, 2/7/02
-
Drug Update: Alzheimer's Disease - Clinical Psychiatry News, 2/03
- Alzheimer's Drugs Help More Than Memory - WebMD, 1/7/03 -
"Four such drugs have been approved by the FDA for use in the U.S. -- Reminyl,
approved in 2001; Exelon, approved in 2000; Aricept, approved in 1996; and Cognex, approved in 1993, but rarely used now
because it can cause liver problems ... treatment with one of these drugs for at least one month slowed the worsening of functional skills such as the ability to dress, bathe and shop. And it improved psychiatric symptoms including depression, hallucinations, delusions,
anxiety, and apathy"
- Rivastigmine Improves Cholinergic Activity in Alzheimer's Disease - Doctor's Guide, 11/29/02
- Rivastigmine May Be Helpful in Subcortical Vascular Dementia - Medscape, 11/22/02
- Rivastigmine, Donepezil Produce Sustained Benefit in Alzheimer's Patients - Doctor's Guide, 10/14/02
- In a Newly Published Study, More Alzheimer's Disease Patients Were Able to Benefit from ARICEPT® (donepezil) Treatment than Exelon® (rivastigmine) - Doctor's Guide, 8/6/02
- In A Newly Published Study More Alzheimer's Disease Patients Were Able To Benefit From Aricept (Donepezil HCl Tablets) Treatment Than Exelon (Rivastigmine Tartrate) - Doctor's Guide, 7/31/02
- Rivastigmine-Risperidone Co-administration Safe in Dementia Patients with Behavioural Disturbances - Doctor's Guide, 7/23/02
- Rivastigmine, Donepezil Combination Well Tolerated and Efficacious - Doctor's Guide, 7/22/02
- Cognitive Decline Rapid and not Regained Following Discontinuation of Acetylecholinesterase Inhibitors - Doctor's Guide, 7/22/02
-
Rivastigmine Appears to Ease Parkinsonian Hallucinations - Clinical Psychiatry News, 6/02
- Switch from Donepezil to Rivastigmine Well Tolerated in Elderly Patients with Alzheimer's Disease - Doctor's Guide, 5/15/02
- Alzheimer's Patients Who Fail On Aricept (Donepezil) May Benefit From Exelon (Rivastigmine) - Doctor's Guide, 5/2/02
-
Acetylcholinesterase Inhibitors Improve Behavior - Clinical Psychiatry News, 4/02
- Up and Coming Drugs for Parkinson's - WebMD, 4/18/02
- Exelon (Rivastigmine) Shows Long-term Efficacy in Alzheimer's disease - Doctor's Guide, 4/5/02
- Exelon (Rivastigmine) Improves Activities of Daily Living Over Course of Alzheimer's Disease - Doctor's Guide, 2/26/02
- Exelon (Rivastigmine) Beneficial In Subcortical Vascular Dementia - Doctor's Guide, 1/28/02
- Rivastigmine Tartrate May Reduce Cognitive Deficits in Patients with Schizophrenia - Doctor's Guide, 11/20/01
- Rivastigmine Provides Behavioral And Cognitive Benefits In Nursing Home Patients With Alzheimer’s - Doctor's Guide, 10/3/01
- Donepezil Preferred To Rivastigmine For Physician Convenience In Alzheimer's Treatment - Doctor's Guide, 6/18/01
- Donepezil and Rivastigmine May Be Combined In Alzheimer's Patients - Doctor's Guide, 5/12/01
- Donepezil Better Tolerated Than Rivastigmine, Efficacy Comparable - Doctor's Guide, 5/11/01 -
"both drugs to provide effective cognitive improvement in patients with Alzheimer’s dementia, but donepezil to
have fewer cholinergic side effects"
- Rapid Switching From Aricept (Donepezil) to Exelon (Rivastigmine) Well Tolerated in Alzheimer's - Doctor's Guide, 5/11/01
- Donepezil Better Tolerated Than Rivastigmine In Alzheimer’s Patients - Doctor's Guide, 2/26/01
- Exelon (Rivastigmine Tartrate) Delays Progression Of Mild To Moderately Severe Alzheimer's Disease - Doctor's Guide, 11/13/00
- Aricept (Donepezil HCl) Better Tolerated Than Exelon (Rivastigmine Tartrate) In Mild And Moderate Alzheimer’s - Doctor's Guide, 9/27/00
- Exelon (Rivastigmine Tartrate) Now Available In US For Alzheimer's Disease - Doctor's Guide, 6/21/00
- FDA Grants Marketing Clearance For Alzheimer’s Drug Exelon (Rivastigmine Tartrate) - Doctor's Guide, 4/24/00
- Different Measurements Used To Show Efficacy Of Alzheimer's Treatments - Doctor's Guide, 4/10/00
- Rivastigmine Helps Maintain Daily Functioning In Alzheimer’s Patients - Doctor's Guide, 10/15/99
- Exelon Effective For Mild To Moderate Alzheimer's - Doctor's Guide, 3/5/99
Abstracts:
Related Searches:
70519
|
